Wonder Drug Inspires Deep, Unwavering Love Of Pharmaceutical Companies

Top Headlines

Science & Technology

Astronomers Just Going To Go Ahead And Say Dark Matter Nitrogen

‘Fuck It, We’re Done,’ Say Scientists

WASHINGTON—Declaring that this is the last time they ever hope to speak of the aggravatingly enigmatic substance, astronomers from NASA announced Thursday that they are just going to go ahead and say that dark matter is nitrogen.

What We’ve Learned About Pluto

Nearly 10 years after its launch, the New Horizons space probe made a flyby 7,750 miles from Pluto, marking the first time in history a spacecraft has examined the dwarf planet up close, and NASA has begun to release data and images transmitted from the approach. Here’s what we’ve learned about Pluto so far

Timeline Of Mass Extinction

Scientists predict that human activity has put the world on the brink of the sixth mass extinction in earth’s history, an event characterized by the elimination of a large number of species within a very short period of time. Here is a timeline of extinction events over the planet’s history

Study: Floating Heap Of Trash Now Ocean’s Apex Predator

SANTA BARBARA, CA—Noting that no marine species posed a threat and the total domination of its habitat, a study released Wednesday by researchers at the University of California, Santa Barbara revealed that the floating mass of trash known as the Great Pacific Garbage Patch is now the ocean’s apex predator.

Dementia Study Reveals Fond Memories First To Go

BALTIMORE—Researchers at Johns Hopkins University published a new study this week on the cognitive effects of Alzheimer’s disease and other deteriorative brain disorders, finding conclusive evidence that dementia sufferers’ fondest memories are nearly always the first to go.

FDA Approves Female-Libido-Enhancing Man

WASHINGTON—In an effort to address the needs of women suffering from a lack of sexual desire, the FDA announced Tuesday that it had approved a new female-libido-enhancing man, which is expected to be made available to the general public by year’s end.

New Report Finds Humanity 10 Years Away From Something Called Ash Age

TUCSON, AZ—Explaining that the large-scale shift in geologic conditions and social organization would require a new taxonomic classification, researchers at the University of Arizona released a report Tuesday revealing that humanity is approximately 10 years away from something that will be called the Ash Age.

NASA Announces Bold Plan To Still Exist By 2045

WASHINGTON—In what is being described as the most ambitious mission ever undertaken in the space agency’s history, NASA officials announced at a press conference Tuesday their bold new plan to still exist by 2045.

YouTube Turns 10

On April 23, 2005, three former PayPal employees started a video-sharing site called YouTube, which has since grown into an influential media platform with over 1 billion users.

Pros And Cons Of Screen Time For Kids

As technology becomes more of a staple in everyday family life, parents are making choices about how much screen time to allow their children—and asking questions about how computers, phones, and TVs might help or hinder a child’s development.

Geologists Unearth Fully Intact Rock

FORT COLLINS, CO—Describing the discovery as the most flawless specimen ever unearthed, a team of geologists working in northern Colorado announced Friday they had excavated a fully intact rock.

Rehabilitated Otter Released Back Into Food Chain

SAUSALITO, CA—Following nine months of surgeries and physical therapy to heal the aquatic animal’s debilitating injuries, officials from the Marine Mammal Center released a fully rehabilitated sea otter back into the food chain Tuesday.

Conservationists Attempting To Get Head Start On Mars

WASHINGTON—Fearing that any further delay might prevent their movement from having any meaningful impact, a consortium of leading conservationists confirmed Wednesday it is attempting to get a head start on preserving the planet Mars. The newly form...

Apple MacBook vs. Google Chromebook Pixel

Shortly after Apple debuted its new ultra-thin MacBook this week, Google announced its new Chromebook Pixel 2, which similarly boasts the new Type-C USB port and high-tech trackpad.

How Cable Companies Plan To Fight Cord Cutting

More consumers than ever are “cord cutting,” or getting rid of their cable service in favor of watching shows online, challenging the cable industry to launch new initiatives in order to keep customers.

Features Of The Apple Car

After dominating sales of smartphones, tablets, and other electronics, Apple is reportedly secretly designing its first car, code-named Titan.

2015 Tech Trends

Showcasing everything from wearable devices to self-driving cars and personal drones, this year’s Consumer Electronics Show revealed the latest in new technology.

Doctors Recommend Getting 8 Centuries Of Cryosleep

STANFORD, CA—Claiming that the practice is essential for effectively recharging the body and waking fully rested and alert, doctors at Stanford University issued a report Monday emphasizing the importance of getting at least eight centuries of atomi...

Scientists Receive $10 Million Grant To Melt Stuff

COLLEGE PARK, MD—Saying the money would help further researchers’ understanding of the awesome scientific phenomenon, representatives for the American Institute of Physics announced Tuesday that they had received a $10 million grant to melt st...

Pfizer Releases Vintage Cask-Aged Robitussin

GROTON, CT—Touting the new offering’s full-bodied flavor and bold, fruit-forward bouquet, pharmaceutical giant Pfizer unveiled a vintage cask-aged variety of its popular cold medicine Robitussin on Friday. Labeled as Robitussin Reserve, the hi...

Apple Releases Brief, Fleeting Moment Of Excitement

CUPERTINO, CA—Ending weeks of anticipation and intense speculation, tech giant Apple unveiled a short and fleeting moment of excitement to the general public Tuesday during a media event at its corporate headquarters.

Startup Very Casual About Dress Code, Benefits

AUSTIN, TX—Touting the business’s laid-back, nontraditional corporate culture, Go-Go Maps founder and CEO Mike Hannasch explained to reporters Thursday that his company is pretty casual when it comes to employees’ dress code and benefits...
End Of Section
  • More News
Up Next
TV Listings
Just Like Everything Else!: Fox 8 p.m. EDT/7 p.m. ABC Pete's wife is still on him about building that darn shed, these kids are going to be the death of Sheila and Dave, and the hot next-door neighbor is up in EVERYBODY'S business! Sunday nights on ABC couldn't be any more familiar!

Special Coverage

Good Times

Wonder Drug Inspires Deep, Unwavering Love Of Pharmaceutical Companies

NEW YORK—The Food and Drug Administration today approved the sale of the drug PharmAmorin, a prescription tablet developed by Pfizer to treat chronic distrust of large prescription-drug manufacturers.

Pfizer executives characterized the FDA's approval as a "godsend" for sufferers of independent-thinking-related mental-health disorders.

PharmAmorin, now relieving distrust of large pharmaceutical conglomerates in pharmacies nationwide.

"Many individuals today lack the deep, abiding affection for drug makers that is found in healthy people, such as myself," Pfizer CEO Hank McKinnell said. "These tragic disorders are reaching epidemic levels, and as a company dedicated to promoting the health, well-being, and long life of our company's public image, it was imperative that we did something to combat them."

Although many psychotropic drugs impart a generalized feeling of well-being, PharmAmorin is the first to induce and focus intense feelings of affection externally, toward for-profit drug makers. Pfizer representatives say that, if taken regularly, PharmAmorin can increase affection for and trust in its developers by as much as 96.5 percent.

"Out of a test group of 180, 172 study participants reported a dramatic rise in their passion for pharmaceutical companies," said Pfizer director of clinical research Suzanne Frost. "And 167 asked their doctors about a variety of prescription medications they had seen on TV."

Frost said a small percentage of test subjects showed an interest in becoming lobbyists for one of the top five pharmaceutical companies, and several browsed eBay for drug-company apparel.

PharmAmorin, available in 100-, 200-, and 400-mg tablets, is classified as a critical-thinking inhibitor, a family of drugs that holds great promise for the estimated 20 million Americans who suffer from Free-Thinking Disorder.

Pfizer will also promote PharmAmorin in an aggressive, $34.6 million print and televised ad campaign.

One TV ad, set to debut during next Sunday's 60 Minutes telecast, shows a woman relaxing in her living room and reading a newspaper headlined "Newest Drug Company Scandal Undermines Public Trust." The camera zooms into the tangled neural matter of her brain, revealing a sticky black substance and a purplish gas.

The narrator says, "She may show no symptoms, but in her brain, irrational fear and dislike of global pharmaceutical manufacturers is overwhelming her very peace of mind."

After a brief summary of PharmAmorin's benefits, the commercial concludes with the woman flying a kite across a sunny green meadow, the Pfizer headquarters gleaming in the background.

PharmAmorin is the first drug of its kind, but Pfizer will soon face competition from rival pharmaceutical giant Bristol-Myers Squibb. The company is developing its own pro-pharmaceutical-company medication, Brismysquibicin, which will induce warm feelings not just for drug corporations in general, but solely for Bristol-Myers Squibb.

"A PharmAmorin user could find himself gravitating toward the products of a GlaxoSmithKline or Eli Lilly," BMS spokesman Andrew Fike said. "This could seriously impede the patient's prescription-drug-market acceptance, or worse, Pfizer's profits in the long run."

"Brismysquibicin will be cheaper to produce and therefore far more affordable to those on fixed incomes," Fike added.

The news of an affordable skepticism-inhibitor was welcomed by New York physician Christine Blake-Mann, who runs a free clinic in Spanish Harlem.

"A lot of my patients are very leery of the medical establishment," Blake-Mann said. "This will help them feel better about it, and save money at the same time."

PharmAmorin's side effects include nausea, upset stomach, and ignoring the side effects of prescription drug medication.